Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06536049
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
- Locations
-
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05873712
- Conditions
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Recurrent Transformed Non-Hodgkin Lymphoma, +5 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT05432635
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06834373
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +39 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
- Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
NCT01035463
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT03321643
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
NCT05627245
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +24 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Yale University New Haven, Connecticut, United States
- University of Kansas Clinical Research Center Fairway, Kansas, United States
- University of Kansas Cancer Center Kansas City, Kansas, United States
Active, Not Recruiting
Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
NCT03150329
- Conditions
- Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +25 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States